In Drosophila, signaling by the epidermal growth factor receptor (EGFR) is required for a diverse array of developmental decisions. Essential to these decisions is the precise regulation of the receptor's activity by both stimulatory and inhibitory molecules. To better understand the regulation of EGFR activity we investigated inhibition of EGFR by the transmembrane protein Kekkon1 (Kek1). Kek1 encodes a molecule containing leucine-rich repeats (LRR) and an immunoglobulin (Ig) domain and is the founding member of the Drosophila Kekkon family. Here we demonstrate with a series of Kek1-Kek2 chimeras that while the LRRs suffice for EGFR binding, inhibition in vivo requires the Kek1 juxta/transmembrane region. We demonstrate directly, and using a series of Kek1-EGFR chimeras, that Kek1 is not a phosphorylation substrate for the receptor in vivo. In addition, we show that EGFR inhibition is unique to Kek1 among Kek family members and that this function is not ligand or tissue specific. Finally, we have identified a unique class of EGFR alleles that specifically disrupt Kek1 binding and inhibition, but preserve receptor activation. Interestingly, these alleles map to domain V of the Drosophila EGFR, a region absent from the vertebrate receptors. Together, our results support a model in which the LRRs of Kek1 in conjunction with its juxta/transmembrane region direct association and inhibition of the Drosophila EGFR through interactions with receptor domain V.
C ELLULAR communication by the epidermal growth and Yarden
. Within the extracellular region the vertebrate ErbBs are composed factor receptor (EGFR) pathway is widely utilized throughout development to specify cellular fates and of four domains. Domains I and III (also known as L1 and L2) mediate ligand binding, whereas the cysteinebehaviors (Schweitzer and Shilo 1997 ; Dominguez rich domains II and IV (also named CR1 and CR2) are et al. 1998; Nilson and Schü pbach 1999; Van Buskirk involved in dimerization and auto-inhibition, respecand Schü pbach 1999). Work in invertebrates and vertetively (Lax et al. 1988; Garrett et al. 2002; Ogiso et al. brates has implicated this pathway in numerous develop-2002; Ferguson et al. 2003) . Interestingly, the extracelmental processes including axial patterning in Drosophlular domain of Drosophila EGFR contains an additional ila, vulval development in Caenorhabditis elegans, and cysteine-rich domain distal to CR2, herein referred to as cardiac development in vertebrates (Aroian et al. 1990;  domain V (Price et al. 1989) . Distal to the kinase domain, Lee et al. 1995; Nilson and Schü pbach 1999) . In addia noncatalytic carboxy-terminal tail (C-tail) contains tyrotion, mutation and misregulation of the EGFR family sines that become phosphorylated in response to ligand of receptor tyrosine kinases (RTK) is one of the hallbinding (Yarden and Schlessinger 1987 ; Ullrich marks of oncogenic transformation and its associated and Schlessinger 1990) . In contrast to the four vertealterations in cellular behavior: immortalization, prolifbrate receptors, Drosophila contains only two isoforms, eration, migration, and invasion (Stoscheck and King EGFR1 and EGFR2, derived from a single locus, torpedo/ 1986; Harari and Yarden 2000; Blume-Jensen and egfr (Clifford and Schü pbach 1994; Lesokhin et al. Hunter 2001; Holbro et al. 2003) . With the exception 1999). These isoforms differ only at their N termini in of the orphan receptor ErbB2 and ErbB3, which encodes the signal sequence and a short stretch of flanking a catalytically inactive kinase domain, the vertebrate and amino acids, but are identical through the ligand-bindinvertebrate receptors are type I transmembrane proing, transmembrane, and cytoplasmic domains. teins composed of an extracellular ligand-binding do-
The long-standing model for activation of EGFR sigmain, a transmembrane region, and a cytoplasmic tyronaling involves receptor homo-or heterodimerization sine kinase domain (Yarden and Ullrich 1988 ; Alroy upon ligand binding (Yarden and Schlessinger 1987; Ullrich and Schlessinger 1990) . This allows for transphosphorylation of a specific subset of tyrosine residues 1 These authors contributed equally to this work.
tion of a variety of cytoplasmic kinase cascades [e.g., RASmolecule Kek1 is induced in a graded fashion by receptor activity (Musacchio and Perrimon 1996; Ghig-RAF-mitogen-activated protein kinase (MAPK) cascade; Yarden and Sliwkowski 2001; Schlessinger and Lemlione et al. 1999) . kek1 was initially identified in an enhancer trap screen for genes involved in the developmon 2003]. However, a wealth of data obtained in the past few years supports a more complex scenario that ment of the Drosophila nervous system. Subsequent molecular and genomic analyses indicated that Kek1 distinguishes the EGFR family among RTKs and indicates that long-held notions about the mechanism of is the founding member of a family of six related transmembrane proteins in Drosophila that contain leu-EGFR activation need to be reexamined (Schlessinger 2000 (Schlessinger , 2002 Burgess et al. 2003) . For example, the recine-rich repeats (LRRs) and a single C2-type immunoglobulin (Ig) domain in their extracellular regions cently solved crystal structures of apo-and ligand-bound soluble forms of EGFR reveal striking differences in the (Musacchio and Perrimon 1996; Adams et al. 2000) . Three lines of evidence support a role for Kek1 in attenmechanism of ligand binding with respect to other RTKs (Garrett et al. 2002 (Garrett et al. , 2003 Ogiso et al. 2002; Ferguson uating EGFR activity during DV patterning (Ghiglione et al. 1999) . First, loss of Kek1 activity results in wider et al. 2003) . Ligand binding may induce a conformational shift involving rotation about the juxta/transspacing between the appendages. This phenotype is dramatically different from that observed in aos mutants, membrane domain of the receptor, thereby resulting in the access of substrate to the kinase domain (Moriki which produce a single, wide appendage, suggesting that Kek1 and Aos utilize distinct mechanisms to inhibit et al. 2001) . Perhaps most surprisingly, structural and functional studies indicate that the EGFR kinase domain EGFR. Second, reduced EGFR activity can be suppressed by the simultaneous elimination of Kek1 activity. is likely catalytically active in a monomeric state (Gotoh et al. 1992; Stamos et al. 2002) . This is in stark contrast Last, misexpression of Kek1 in follicle cells results in inhibition of EGFR signaling, observed phenotypically to other members of the RTK family (e.g., insulin receptor), which require tyrosine phosphorylation in the actias ventralization of the chorion. More recently, lossof-function studies in the eye, as well as misexpression vation loop (A-loop) of the kinase domain for full catalytic activity (Hubbard and Till 2000) . While kinase studies in both the eye and the wing, indicate that Kek1 is likely to function as a general inhibitor of EGFR activity is essential to signaling, receptor dimerization, ligand binding/dissociation, subcellular localization, throughout development (Ghiglione et al. 2003; Alvarado et al. 2004 ). In addition, deletion analyses and trafficking, and effector transduction all play important roles in regulating signaling strength (Olayioye et al. mutagenesis experiments have demonstrated that the LRRs of Kek1 play an essential role in receptor inhibi-2000). The integration of such regulatory mechanisms is therefore essential to specify the appropriate level of tion (Ghiglione et al. 2003; Alvarado et al. 2004) . Despite recent progress in elucidating the mechanism EGFR signaling within a given developmental context.
Although the relevance of positive effectors of EGFR of Kek1 function, a number of questions remain unanswered. Currently, it is unclear what elements of Kek1 signaling has long been appreciated, only in the past few years has the importance of inhibitory molecules in suffice for inhibition, whether other Kek molecules function redundantly with Kek1, and if Kek1 is a subregulating signaling strength and duration come to the forefront . Molecules such as Kekkon1 strate for EGFR-mediated phosphorylation. Here we present evidence addressing these questions. Impor-(Kek1), Argos (Aos), D-Cbl, and Sprouty (Spry) inhibit EGFR signaling, resulting in a refinement of signaling tantly, we show that while the Kek1 LRRs promote binding, the juxta/transmembrane region of Kek1 actively output (Schweitzer et al. 1995; Hime et al. 1997; Wasserman and Freeman 1998; Casci et al. 1999; Ghigli- contributes to receptor inhibition. We demonstrate that EGFR inhibition is unique to Kek1 among the Kek famone et al . 1999 , 2003 Kramer et al. 1999; Pai et al. 2000) . Furthermore, all these inhibitors exert their effects via ily members, that Kek1 is not a substrate for EGFR phosphorylation, and confirm that Kek1 inhibits EGFR different mechanisms, resulting in distinct effects on receptor signaling. Characterizing the mechanisms by in multiple developmental contexts. Finally, we have isolated a unique class of EGFR alleles that specifically which all EGFR regulators work will be essential to understanding the balanced interplay between these moledisrupt its association with Kek1. cules and their contribution to EGFR-mediated developmental decisions.
MATERIALS AND METHODS
The specification of dorsal-ventral (DV) polarity in Drosophila provides one well-characterized example of Drosophila genetics: Flies were raised at 27Њ on standard media. The following stocks were used: follicle cell drivers the interplay between positive and negative effectors of P{GawB}CY2 (Queenan et al. 1997) and P{GawB}T155 (Free-EGFR signaling. During the latter stages of oogenesis, man 1996); eye driver P{GAL4-ninaE.GMR} (Freeman 1996);  receptor activity is modulated by positive and negative P{w ϩ mC ϭ Act5C-GAL4}; feedback loops to pattern the DV axis (Stevens 1998; man 1996) , and kek1 RM2 (MusacpUAST-Kek2-gfp was made by amplifying the full-length gene from the NB7 cDNA and subcloning into a basal pUAST-gfp chio and Perrimon 1996). Transgenic lines were generated by coinjecting each pUAST construct with transposase (pUChs using 5Ј EcoRI and 3Ј KpnI sites. Additional details and maps are available upon request. ͟ ⌬2-3) at a 4:1 ratio into w 1118 embryos. All pUAST constructs were misexpressed in follicle cells Kek1-Kek2 swaps were generated in vitro by overlapping PCR. Purified fragments were cloned into a Gateway-compatiusing CY2-GAL4 or T155-GAL4 and in the developing eye with GMR-GAL4. , DNA was isolated in PBS and fixed for 10 min in 3.7% formaldehyde/PBS, washed three times in , and brought to from 30-50 homozygous embryos selected from egfr SOK5 /CyO, P{Act-GFP} stock. Likewise, genomic DNA was also isolated volume in 70% glycerol/PBS with SlowFade (Molecular Probes, Eugene, OR). GFP fluorescence images were captured from w;iso2;iso3 adults. egfr exons were amplified individually by PCR, using primers specific to noncoding sequence flankwith a Leica TCS SP confocal microscope. Wings were dehydrated in 100% ethanol and mounted in polyvinyl lactopheing each exon, purified using a gel purification kit (QIAGEN), and sequenced using cycle sequencing according to the manunol. Scanning electron microscopy was performed as in Kimmel et al. (1990 Cherbas (1998) . Cells were grown to a density of ‫5ف‬ ϫ 10 6 cells/ml and transfected by electroporation. Cells were cotranssuppressors were then mapped using standard recombination mapping techniques to genetic position 97-99 on 2R with the fected with 5 g of metallothionein-GAL4 (mt-GAL4; Klueg et al. 2002) , a copper-inducible GAL4 driver, and 5 g of responder following stocks: al 1 dp ov1 Molecular cloning and sequence analysis: keg-based chimeand subsequently lysed in 1 ml of ice-cold Fehon buffer (Fehon et al. 1990 ) containing 1 mm PMSF, 1 m leupeptin, ras were subcloned into pUAST in three steps. The kek1 extracellular and transmembrane region was amplified by PCR and 1 m pepstatin A, and 0.3 m aprotinin. Lysed cells were cleared by centrifugation at 14,000 rpm for 5 min at 4Њ. Supersubcloned into pUAST using 5Ј EcoRI and 3Ј BglII sites (pUASTk1et). The gfp gene was excised from the pEGFP-N1 vector natant was brought up to 5 ml in buffer, and antigen was immunoprecipitated with 0.5 l of rabbit anti-GFP (CLON-(CLONTECH, Palo Alto, CA), using 5Ј KpnI and 3Ј XbaI restriction sites, and fused in frame to pUAST-k1et (pUAST-k1et-TECH). Samples were rotated for 2 hr at 4Њ and subsequently incubated with 150 l of a 1:5 slurry of protein A Sepharose gfp). Next, variants of the cytoplasmic domain of egfr were flanked with 5Ј BglII and 3Ј KpnI sites by PCR and incorporated beads (Amersham-Pharmacia, Piscataway, NJ) in Fehon buffer for 1 hr at 4Њ. Beads were collected by gentle centrifugation into pUAST-k1et-gfp. Fragments encode the full-length cytoplasmic domain (keg), the kinase region (ke ⌬C g), and the C-tail (3000 rpm for 2 min at 4Њ) and washed five times in Fehon buffer. The last two washes were performed in Fehon buffer (ke ⌬K g ). Point mutations encoding kinase-dead chimeras were generated by PCR-based site-directed mutagenesis utilizing lacking detergent. Samples were resuspended in 30 l of a 3:2 mix of 5ϫ sample buffer and TBS, boiled for 5 min, and mismatch primers encoding G901R (ke* g g ) and K923M (ke* k g ) changes in the kinase region. pUAST-mCD8E ⌬C -gfp was conloaded in 8% polyacrylamide gels. Transfer to nitrocellulose membranes (Amersham-Pharmacia) was followed by Ponceau structed by substituting the kek1 region in pUAST-ke ⌬C g with a PCR-based fragment from pUAST-mCD8-gfp (courtesy of Liqun staining and subsequently blocked for 1 hr at room temperature (RT) in 5% nonfat dry milk (NFDM) with TBST (100 Luo; Lee and Luo 1999) encoding extracellular and transmembrane regions of the murine CD8 gene flanked by 5Ј MfeI mm Tris pH 7.5, 150 mm NaCl, 0.1% Tween-20). Membranes were incubated with primary antisera at the following concenand 3Ј Bgl II restriction sites.
pUAST-kek1-gfp was made by first subcloning a PCR-based trations: rabbit anti-EGFR (courtesy of Nick Baker; Lesokhin et al. 1999) at 1:5000 (2% NFDM in TBST), monoclonal antifragment flanked by 5Ј SpeI and 3Ј KpnI sites encoding the transmembrane-intracellular regions of kek1 into pUAST-gfp GFP (CLONTECH) at 1:1000 (5% NFDM in TBST), and guinea pig anti-Delta (courtesy of Marc Muskavitch; Huppert (pUAST-kek1tm-intra-gfp). Next, the extracellular domain of kek1 was amplified by PCR from its cDNA (NB1) and cloned et al. 1997) at 1:5000 (5% NFDM). Incubations were done overnight at 4Њ, followed by five washes in TBST. Secondary into pUAST-kek1tm-intra-gfp using 5Ј EcoRI and 3Ј SpeI sites.
horseradish peroxidase-conjugated goat-anti-rabbit, mouse, pressed them during oogenesis using CY2-GAL4. Misexand guinea pig antibody incubations (Jackson Immunorepression of these Keks in follicle cells has no effect on search, West Grove, PA) were done at 1:20,000 in 5% NFDM DV patterning, indicating Kek2, Kek4, Kek5, and Kek6 for 1 hr at RT, followed by five washes in TBST. Detection are not functionally analogous to Kek1 with respect to was performed by chemiluminescence (West Pico; Pierce, Rockford, IL), according to manufacturer's instructions, utiliz-EGFR inhibition ( Figure 1C ). Thus, the ability to associing Kodak Biomax MR-1 autoradiography film. Stripping and ate with and inhibit the EGFR is not a common feature reprobing was performed according to manufacturer's instrucshared by Kek family members and is unlikely to provide tions.
an explanation for subtlety of the kek1 null phenotype.
Phosphorylation assays: Ten ovaries per genotype were dis-
Kek1 attenuates receptor signaling in multiple tissues:
sected in PBS and homogenized in 500 l of RIPA buffer with protease and phosphatase inhibitors (150 mm NaCl, 100 mm Initially, the subtlety of the loss-of-function phenotype Tris pH 7.4, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, for kek1 hindered identification of its role in EGFR sig-1 mm PMSF, 1 m leupeptin, 1 m pepstatin A, 0.3 m aprotinaling. Subsequently, however, a role for kek1 in attenunin, 5 mg/ml ␤-glycerolphosphate, 1 mm sodium orthovanaating EGFR signaling during oogenesis was uncovered date). Ovaries were homogenized and cleared by centrifugain DV patterning, as determined by misexpression analytion for 10 min. Supernatant was brought up to 1 ml and immunoprecipitations and Western blots were performed as sis and confirmed through loss-of-function studies (Ghigdescribed above. Anti-phosphotyrosine (pY99; Santa Cruz Biolione et al . 1999) . In addition to its role in DV pattechnologies, Santa Cruz, CA) was used at 1:1000 in 4% BSA.
terning, the EGFR participates in a multitude of cellular Rabbit anti-EGFR and mouse anti-␣ tubulin (Accurate Chemidecisions throughout development, where distinct lical, Westbury, NY) antibodies were used at 1:5000.
gands regulate receptor activity in a tissue-specific fashion. It has recently been shown through misexpression experiments that Kek1 can inhibit EGFR signaling in RESULTS the wing and eye (Ghiglione et al. 2003 In its extracellular region Kek1 is composed of more generally throughout development to attenuate an N-terminal insert, a set of seven LRRs flanked by receptor activity, we generated flies with reduced egfr cysteine-rich caps, and a single Ig domain, which toactivity and asked whether the resulting phenotypes gether with the transmembrane domain suffice to incould be rescued by simultaneous removal of kek1. Prior hibit EGFR signaling. Within the Drosophila proteome, to DV patterning, EGFR activity in the posterior follicle significant sequence similarity and a similar arrangecells results in the establishment of the anterior-postement of motifs are found in five additional transmemrior (AP) axis. Hypomorphic combinations of egfr result brane proteins that together with Kek1 constitute the in abnormal AP axis specification and mislocalization Kekkon (Kek) family (Musacchio and Perrimon 1996;  of the posterior determinant oskar (osk; Roth et al. 1995; Derheimer et al. 2004) . The identification of these struc- Figure 2D ). Simultaneous removal of kek1 activity supturally related molecules coupled with the subtlety of presses this phenotype, allowing the proper establishkek1 null phenotype raised the possibility of functional ment of the AP axis ( Figure 2F ). Likewise, a similar redundancy among Kek family members. To address role for kek1 is observed during wing vein specification, this we tested four of the five additional members, Kek2, which also requires EGFR signaling (Diaz-Benjumea Kek4, Kek5, and Kek6, for effects on EGFR signaling in and Garcia-Bellido 1990; Sturtevant et al. 1993) . vitro and in vivo. Initially, we confirmed that both EGFR Hypomorphic combinations of egfr result in vein loss isoforms (1 and 2) associate with Kek1 and each other ( Figure 2C ) and simultaneous removal of kek1 also supby co-immunoprecipitation (co-IP) experiments from presses this phenotype ( Figure 2E ). Consistent with an Drosophila S3 cells (Figure 1, A and B) . Kek1, in addiincrease in EGFR activity in a kek1 Ϫ background, patches tion to binding the receptor, is also able to associate of ectopic vein are also present in kek1 Ϫ wings (Figure with itself (Alvarado et al. 2004) . Indicating specificity 2F). Strong dose-dependent inhibitory effects for ento binding, Kek1 does not associate with the transmemdogenous kek1 on EGFR signaling have also been obbrane molecule Delta (Dl; Figure 1B) . In contrast to the served in the developing eye (Alvarado et al. 2004) . strong interaction detected between Kek1 and EGFR, Since EGFR activation within each tissue is initiated by Kek2, Kek4, and Kek5 interact either weakly or not at distinct ligands, our results suggest that Kek1's inhibiall with EGFR in co-IPs ( Figure 1B) . tory activity is neither ligand nor tissue specific, consisConsistent with the ability of Kek1 to physically associtent with misexpression analyses (Neuman-Silberberg ate with the receptor, its misexpression during oogenand Schü pbach 1993; Roth et al. 1995; Simcox 1997; esis with CY2-GAL4 results in inhibition of EGFR sigTio and Moses 1997; Ghiglione et al. 1999 Ghiglione et al. , 2003 ; naling and ventralization phenotypes similar to those Guichard et al. 1999; Alvarado et al. 2004) . However, observed with loss-of-function alleles of the receptor.
it is important to note that these results do not exclude To determine if other Kek family members displayed the possibility that Kek1 binds all EGFR ligands and inhibitory effects similar to Kek1 in vivo, we generated might function as a ligand sink. Given that Kek1 can also associate with itself, one possibility is that Kek1 acts UAS lines for Kek2, Kek4, Kek5, and Kek6 and misex- , and a monoclonal anti-GFP antibody as a control (middle). Whole-cell lysates were directly immunoblotted with anti-EGFR and anti-Delta as a loading control (bottom). Kek1GFP associates with both isoforms of EGFR (iso1 and iso2) whereas Kek2GFP, Kek4GFP, and Kek5GFP display minimal or no affinity for EGFR. (C) Chorion phenotypes and subcellular distribution of GFP-tagged constructs misexpressed in follicle cells with CY2-GAL4. Kek1GFP exhibits strongly ventralized chorions, whereas Kek2GFP, Kek4GFP, Kek5GFP, and Kek6GFP do not display ventralized chorions when misexpressed with CY2-GAL4, demonstrating that the extracellular and transmembrane domains of Kek1 are unique in their ability to inhibit EGFR among Kek family members.
as a homodimer and competes with the receptor for tivity, we were able to test the ligand sink model, using a chimeric Kek1-EGFR molecule. The extracellular and ligand binding (Alvarado et al. 2004) . Work with Kek1 and the vertebrate receptor has recently provided suptransmembrane portions of Kek1 were fused to a portion of the cytoplasmic domain of the EGFR including port against such a model by indicating that Kek1 does not appear to act simply by binding to vertebrate EGF the kinase domain, but lacking all residues following the kinase domain-the C-tail. In Drosophila, as with (Ghiglione et al. 2003 ). Below we also rule out the ligand sink model in Drosophila.
the vertebrate receptors, the EGFR C-tail contains a series of tyrosines that recruit adaptor proteins upon Kek1 acts in association with EGFR in vivo and not as a ligand sink: To address the potential for Kek1 to phosphorylation and is essential for signaling activity (Raz et al. 1991; Clifford and Schü pbach 1994) . The function as a competitive inhibitor of EGFR through ligand binding in Drosophila, we took advantage of the absence of the C-tail from this chimera prevents it from undergoing autophosphorylation as a homodimer. This knowledge that chimeric proteins have been widely used in Drosophila to study the function of transmembrane Kek1-EGFR chimera was tagged with GFP and termed KE ⌬C G ( Figure 3A ). receptors (Dickson et al. 1992; Reichman-Fried et al. 1994; Murphy et al. 1995; Queenan et al. 1997; Schnepp If Kek1 functions as a competitive inhibitor through homodimerization and ligand binding, the KE ⌬C G chiet al. 1998; Boutros et al. 2000; Keleman and Dickson 2001; Keleman et al. 2002) . Since the extracellular and mera would still function as an inhibitor, since it could bind ligand but would fail to activate EGFR signaling transmembrane portions of Kek1 mediate inhibitory ac- /kek1 RM2 egfr CO males. As observed in C, loss of the anterior cross-vein (100%, n ϭ 49) and partial loss of the L4 wing vein (69%, n ϭ 49) are evident. In E, restoration of L4 in egfr mutants is observed in response to elimination of kek1 as no gaps were observed in the double mutants (0%, n ϭ 47 due to the absence of the C-tail. Alternatively, if Kek1 transmembrane molecule CD8 was similarly tagged with the EGFR intracellular domain lacking its C-tail and GFP and EGFR function as a heterodimer in vivo, KE ⌬C G would bind and cross-phosphorylate the endogenous (mCD8E ⌬C GFP; Figure 3A ). Misexpression of either this molecule or a form of EGFR lacking the extracellular receptor ( Figure 3B ). In this scenario, misexpression of KE ⌬C G would result in EGFR activation, rather than domain (⌬TOP; Queenan et al. 1997) did not activate signaling in our assay ( Figure 3C and data not shown), inhibition, confirming the presence of a Kek1/EGFR complex in vivo and providing evidence against the liindicating that the kinase domain of EGFR alone does not trigger signaling. Therefore, the extracellular and gand sink model. Misexpression of KE ⌬C G in follicle cells resulted in dorsalized chorions, an EGFR gaintransmembrane portions of Kek1 are sufficient to direct association with EGFR in vivo in a ligand-independent of-function phenotype, strongly suggesting that it is able to activate signaling via a direct interaction with fashion. A similar conclusion was also made using a Kek1-EGFR chimera that includes the C-tail of EGFR the receptor ( Figure 3C ). Consistent with this, KE ⌬C G associates strongly with EGFR1 by co-immunoprecipita- (Ghiglione et al. 2003) .
Kek1 forms an inhibitory complex with EGFR:
The tion ( Figure 3D ). Similar stimulatory effects were also observed in the wing and eye (data not shown). If this physical association of Kek1 with the receptor noted in vivo is consistent with a model for inhibition in which chimera requires endogenous EGFR for its activity, then reducing access to EGFR should result in suppression receptor dimerization and autophosphorylation are precluded by association with Kek1 (Ghiglione et al. of its activity. Consistent with this, hemizygosity for egfr, heterozygosity with receptor alleles lacking the C-tail, 2003) . Although this provides a simple explanation for the lack of receptor signaling, the status of receptor or misexpression of a dominant-negative allele of egfr (DNegfr) resulted in partial or complete suppression kinase activity when complexed with Kek1 remains an important and unresolved issue (Burgess et al. 2003 G associates strongly with EGFR by co-IP, whereas mCD8E ⌬C GFP binds weakly. This is likely due to a weak affinity of the EGFR kinase domain for itself, since a similar mCD8 construct lacking the EGFR portion does not associate with EGFR. Stamos et al. 2002) . Thus, we were prompted to investistrong inhibition of EGFR signaling. In ovaries from CY2-GAL4, UAS-Kek1-GFP females, no detectable tyrogate two possible models for Kek1 inhibition of EGFR. In one model, the receptor kinase domain has access sine phosphorylation of Kek1 is evident, supporting the latter model (Figure 4 ). To provide additional support to and phosphorylates Kek1, which then acts as a "dead end" substrate by failing to bind the appropriate downfor this, we tested a series of chimeric Kek1/EGFR molecules designed to functionally assay the activity of the stream adaptors. Alternatively, Kek1 may not be phosphorylated when complexed with EGFR, suggesting that receptor when complexed with Kek1. If Kek1 is phosphorylated by EGFR and acts as a dead end substrate, the receptor kinase domain is unable to gain access to Kek1 for trans-phosphorylation. Such a scenario would then exchanging the cytoplasmic domain of Kek1 with a phosphorylation and signaling-competent substrate be consistent with evidence suggesting that rotation of the receptor transmembrane domain is necessary for (EGFR cytoplasmic domain) would enable recruitment of the appropriate adaptor proteins, thereby converting activation (Moriki et al. 2001) . To address these two models we utilized both a biochemical and a genetic Kek1 to an activator ( Figure 5, A and B) . In contrast, if Kek1 is not a substrate for phosphorylation, no transapproach to examine the status of Kek1 as a phosphorylation substrate in vivo.
phosphorylation of this Kek1/EGFR chimera would occur, thereby maintaining Kek1's function as an inhibitor First, we assayed for tyrosine phosphorylation of Kek1 under conditions in which its misexpression results in ( Figure 5B ). These chimeras contain the extracellular 
Females misexpressing either Kek1 or KE ⌬C G in follicle cells using CY2-GAL4 were combined with the alleles depicted in each column. Chorion phenotypes are represented in parentheses, denoting a range from severely ventralized (V4) to severely dorsalized (D3). Misexpression of Kek1 in follicle cells suppresses the dorsalization effect of a secreted form of Grk (UAS-grk ⌬TC ). The dorsalization effect of KE ⌬C G is completely suppressed when misexpressed with kek1 (UAS-kek1) or a dominant negative form of EGFR (DNegfr) G contains an internal deletion encompassing the entire kinase domain (Qian et al. 1995 ; deficient forms of the intracellular domain of EGFR tagged with GFP (KEG; Figure 5A ). Three distinct kiKlingbeil and Gill 1999).
As with Kek1, all three chimeras associate with the nase-deficient forms of KEG (KE shown). Demonstrating that these chimeras are funcPrevious reports have demonstrated that a receptor with tional inhibitors, their misexpression in follicle cells an intact kinase can trigger signaling by trans-phosphorresulted in strongly ventralized chorions, a phenotype ylation of a kinase-deficient EGFR, indicating that a comparable to that observed with Kek1 misexpression kinase-deficient receptor is capable of acting as a func-( Figure 5D ). Similar inhibitory effects were also obtional signaling substrate in vivo (Raz et al. 1991; Clif- served in other tissues (data not shown). Similar results ford and Schü pbach 1994; Guichard et al. 2002) . Likewere obtained with a form of KE g G that lacks the GFP wise, the Kek1/EGFR chimeras could act in a manner tag (KE g ), indicating that GFP does not interfere with analogous to the vertebrate kinase-deficient receptor the function or structure of the chimeras ( Figure 5D ). ErbB3, which signals by serving as a phosphorylation
As an additional control, we confirmed that the cytosubstrate for other ErbB family members (Sliwkowski plasmic domain of EGFR is able to act as a functional et al. 1994; Kim et al. 1998) . The first two chimeras, KE g G phosphorylation substrate in a chimeric situation. We and KE k G, contain point mutations that disrupt ATP took advantage of the fact that Kek1 is able to homobinding and phospho-transfer, respectively, whereas the dimerize and created a control chimera, KEG, with a functional EGFR kinase domain. KEG is heavily phosphorylated in vivo and its misexpression results in dorsalization of the chorion in the presence or absence of receptor activity, consistent with the formation of homodimers and EGFR-independent activation of signaling ( Figure 4 and Figure 5 , A, C, and D). This demonstrates that the cytoplasmic domain of EGFR in a Kek1 chimera is able to act as a functional signaling substrate in vivo and that the kinase activity of the inhibitory chimeras was effectively abolished by the kinase domain point mutations. Together our results argue that Kek1, as well as the chimeras, is not a phosphorylation substrate for EGFR. This supports the latter model in which the receptor kinase domain is unable to access Kek1 is required to appropriately position the kinase domain degrees of inhibitory activity when assayed in vivo (Figure 6 , B and C). The LRR (L), Ig (I), and jt/tm (T) relative to its substrate. In this scenario, the structure of the Kek1 juxta/transmembrane (jt/tm) region might swap (LIT), which includes the entire extracellular and transmembrane portion of Kek1 in place of the correact to sterically hinder rotation. Consistent with an active role for the Kek1 jt/tm region, analysis of a series of sponding portion of Kek2, displays inhibition equivalent to full-length Kek1 (refer to Figures 1 and 6C ). In condomain swaps between Kek1 and Kek2 indicates that while the LRRs suffice for binding, the jt/tm region of trast, the next two swaps, which include only the LRRs and Ig (LI) or the LRRs (L) of Kek1, respectively, but Kek1 is necessary for full inhibitory activity in vivo (Figure 6 ). Three swaps, each containing progressively less lack the jt/tm portion of Kek1, have minimal inhibitory activity in the ovary, eye, and embryo ( Figure 6C ). Thus, of the extracellular/transmembrane portion of Kek1 fused to Kek2, were constructed and assayed for binding while the LRRs of Kek1 suffice for receptor binding, the jt/tm region of Kek1 is specifically required, in addiand inhibition of EGFR activity in vivo ( Figure 6 ). All three swaps bind to the receptor, but display different tion to the LRRs, for full inhibition of the receptor in Figure 6 .-The juxta/ transmembrane region of Kek1 actively contributes toward EGFR inhibition. (A) Three constructs were generated where increasingly smaller portions of Kek1 were swapped with the corresponding regions of Kek2. LITGFP encodes Kek1's LRRs, Ig, and juxta/tm regions and Kek2's cytoplasmic domain. LIGFP encodes the LRRs and Ig domain of Kek1 and the juxta/tm and cytoplasmic regions of Kek2.
LGFP contains only the Kek1 LRRs (including the cysteine-rich flanks). (B) Like full-length Kek1, these chimeras bind EGFR (top), demonstrating that the Kek1 LRRs are sufficient for associating with EGFR. In contrast, Kek2 binds EGFR weakly. (C) Misexpression of LITGFP in follicle cells with CY2-GAL4 results in strongly ventralized chorions, a phenotype similar to that of full-length Kek1. LIGFP and LGFP inhibit weakly, demonstrating that the juxta/tm region of Kek1 is necessary for full inhibition. Similar activities were also observed with GMR-GAL4 and Act5C-GAL4. V1-V3 denotes increasing degrees of ventralization, while R1-R3 denotes increasingly stronger rough eye phenotypes. Parentheses represent the number of independent transgenic lines tested.
vivo. Supporting this, secreted forms of Kek1 (sKek1, shown). The SOKs do not interact indiscriminately with other molecules, but rather act in a dominant fashion sKek1GFP), display no inhibitory activity when assayed with CY2-GAL4 (data not shown; Ghiglione et al. 2003) .
to suppress Kek1-mediated increases or decreases in EGFR signaling. Novel alleles of EGFR disrupt binding and inhibition by Kek1: One simple interpretation of the current data
The first hint that the SOKs were not standard lossof-function (LOF) mutations was their ability to supis that the LRRs direct association with the receptor, while the jt/tm region of Kek1 facilitates inhibition. In press increases and decreases in EGFR signaling. Further supporting the notion that the SOKs represent light of this possibility and the knowledge that Kek1 and EGFR interact directly, we reasoned that identificaunique mutations, the SOKs all map to the same region and deficiencies for this region fail to suppress the GMRtion of suppressors of Kek1 misexpression phenotypes would likely identify mutations in EGFR that disrupt this kek1 eye phenotype. Since the SOKs mapped to the vicinity of the receptor, we hypothesized that they represent association, providing further insight to the mechanism underlying their association. To identify such suppresunique alleles of the receptor, defective primarily in their ability to associate with Kek1. By eliminating the sors, an F 1 mutagenesis screen was employed to detect dominant mutations that suppress the effects of Kek1 receptor's ability to associate with Kek1, these alleles would effectively prevent Kek1 or the Kek1/EGFR chimisexpression in the eye (Freeman 1996; Figure 7A ). From this screen five dominant suppressors of Kek1, or meras from affecting receptor signaling. Confirming this, SOK5, the only homozygous lethal SOK mutation, SOKs, that suppress the effects of Kek1 misexpression both in the eye (GMR-GAL4; UAS-kek1) and in the ovary fails to complement alleles of egfr and contains a single missense mutation altering codon 750 (TAC to TGC), (CY2-GAL4; UAS-kek1), were recovered (Figure 7 , B-K). To further address the specificity of the SOKs, we examconverting tyrosine to a cysteine (Y750C; Figure 9A ). Thus, SOK5 represents a novel allele of the receptor that ined their ability to suppress phenotypes associated with misexpression of DN-EGFR, Aos, Kek family members, acts in a dominant fashion to suppress Kek1-dependent effects on EGFR signaling. Likewise, molecular analysis and the Kek1/EGFR chimeras. Strikingly, the SOK mutations suppress only the effects of molecules containing indicated that the remaining four SOKs, SOK1, SOK2, SOK3 and SOK4, also contain missense mutations in the extracellular and transmembrane domain of Kek1, including both the inhibitory chimera KE g G and the the receptor. SOK4 alters codon 718 (GAG to AAG), converting glutamic acid to a lysine (E718K), while activating chimera KE ⌬C G (Figure 8 and data not SOK1, SOK2, and SOK3 alter codon 738 (CGA to CAA), while concomitantly disrupting its ability to associate with Kek1. To test this directly, we assayed the ability converting arginine to a glutamine (R738Q; Figure 9A ).
of the EGFR SOK molecules to associate with full-length Together the five SOKs represent changes to three resiKek1, the activating chimera KE ⌬C G, or wild-type EGFR dues spanning only 32 amino acids in the extracellular in co-immunoprecipitations. Supporting our model, portion of the receptor. Moreover, they all lie within EGFR SOK has reduced affinity for both full-length Kek1 domain V, a region absent from all vertebrate orthologs and KE ⌬C G, but is able to associate efficiently with the of the receptor ( Figure 9C ). Finally, all of the SOKs are wild-type receptor ( Figure 9B ). Consequently, domain able to promote eye development (in the presence of V is crucial in mediating the receptor's interaction with Kek1 misexpression) and therefore must retain the abiland subsequent inhibition by Kek1. ity to dimerize and initiate downstream signaling events. Consistent with this, the egfr alleles are viable mutations and hence do not affect any vital functions of the DISCUSSION receptor. In contrast, the lethality of egfr SOK5 indicates that it disrupts functions of the receptor essential for Throughout development, EGFR activity specifies disviability, in addition to its effects on Kek1.
tinct cellular responses. Essential to this ability is the On the basis of our model, we predict that the SOK existence of an integrated network of regulatory molecules that direct receptor activity. Kek1, a member of a alleles retain the receptor's ability to homodimerize, family of LRR-and Ig-containing molecules, represents inhibition in vivo. Indeed, full inhibition is restored only when the entire extracellular and transmembane a component of this network through its role as a feedback inhibitor of receptor activity. Deletion and mutaregions of Kek1 are placed in the context of a Kek2 backbone. This result supports an active role for the genesis studies have now demonstrated that the LRRs of Kek1, specifically LRR2 and G160, are essential for Kek1 jt/tm domain in inhibition, as a chimera containing the Kek1 LRRs in a Kek2 backbone is membrane its association with, and consequently inhibition of, the receptor (Ghiglione et al. 2003; Alvarado et al. 2004;  tethered, but a weak inhibitor. This indicates that LRRmediated binding alone is insufficient for receptor inhi- Figure 10 ). The Kek1 cytoplasmic domain and associated Kek1 tail (KT) box have also been implicated in bition. Rather, our results suggest that Kek1-mediated inhibition of EGFR signaling is a bipartite process, in the inhibitory process, possibly through effects on subcellular trafficking (Ghiglione et al. 2003 ; Derheimer which the LRRs dictate EGFR binding and the jt/tm region facilitates inhibition (Figure 10 ). Phylogenetic et al. 2004 ; Figure 10 ).
Bipartite inhibition-the LRRs and jt/tm of Kek1 are analysis has indicated that this region is well conserved in Kek1 orthologs, supporting an important functional required for EGFR inhibition: While it is clear that the Kek1 LRRs are essential for EGFR binding and inhibirole for this region (Derheimer et al. 2004) . Given this requirement for the Kek1 jt/tm region in inhibition, it tion, secreted forms of Kek1 are nonfunctional, indicating that membrane anchoring is likely to be an essential was interesting to note that the SOK alleles identify three amino acids present in domain V of the receptor. element to the inhibitory mechanism (Ghiglione et al. 2003; this article) . Directly testing this, our Kek1-Kek2
Alteration of these three residues renders the receptor refractory to inhibition by Kek1 and activation by KE ⌬C G, swaps demonstrate that while the Kek1 LRRs are sufficient for binding in vitro, they provide only minimal respectively. Moreover, two of the changes, R738Q and al. 2002) . Such a configuration is unique in that receptor tyrosine kinases normally require activation loop V in mediating regulation by Kek1. It is interesting to note that EGFR domain V represents a third cysteinephosphorylation to relieve autoinhibitory interactions that prevent substrate binding and phosphorylation rich domain in Drosophila, which is absent in the vertebrate ErbBs. This raises intriguing structural and evolu- (Gotoh et al. 1992; Burgess et al. 2003) . In light of a distinct mechanism for activation of EGFR, one protionary questions, as Kek1 has been reported to associate with all human ErbBs (Ghiglione et al. 2003) . It will posal put forth is the rotation twist model, in which ligand binding induces dimerized receptors to pivot in be important in the future to define those elements in the receptor that suffice for its inhibition by Kek1 and or near the transmembrane domain, thereby reorienting the kinase domains to their substrates. One potential determine if additional distinctions in the interactions between Kek1 and the different receptor family memexplanation for the inability of the receptor to phosphorylate Kek1 is that the structure of the Kek1 jt/tm bers exist.
We also provide both direct (absence of phosphorylaregion might act to hinder such a rotation. Inhibition of EGFR is not a common Kek family function) and indirect evidence (chimeras) that Kek1 is not a phosphorylation substrate for the receptor. This was tion: Considering that kek1 knockouts exhibit subtle and dose-dependent phenotypes, one important question somewhat surprising, as structural work with the verte-Kaufman for advice and equipment; K. Klueg and L. Cherbas for advice in cell culture experiments; F. Rudi Turner for assistance with the SEMs; Tim Evans, Brandon Weasner, and Christopher Skipwith for their contributions to this work; and C. Ghiglione and K. Carraway III for sharing results prior to publication. We gratefully acknowledge the help of W. 
